BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAH4. A total of 50 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,709,000 | -10.5% | 10,000,000 | -9.1% | 0.63% | +21.3% |
| Q2 2023 | $10,848,475 | -9.7% | 11,000,000 | -6.0% | 0.52% | +40.7% |
| Q1 2023 | $12,018,591 | +25.6% | 11,700,000 | +30.0% | 0.37% | +23.7% |
| Q4 2022 | $9,569,790 | +17.2% | 9,000,000 | +9.8% | 0.30% | +9.5% |
| Q3 2022 | $8,163,000 | +0.2% | 8,200,000 | 0.0% | 0.27% | +7.5% |
| Q2 2022 | $8,143,000 | +7.8% | 8,200,000 | +9.3% | 0.26% | +21.4% |
| Q1 2022 | $7,552,000 | – | 7,500,000 | – | 0.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wellesley Asset Management | 53,670 | $57,726,000 | 3.34% |
| SHENKMAN CAPITAL MANAGEMENT INC | 26,959,000 | $29,149,000 | 3.04% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 84,134,000 | $90,539,000 | 1.93% |
| Cheyne Capital Management (UK) LLP | 3,220,000 | $3,452,000 | 1.75% |
| PFM Health Sciences, LP | 40,300,000 | $43,210,000 | 1.52% |
| Sonora Investment Management, LLC | 6,370,000 | $6,807,000 | 0.56% |
| MACKAY SHIELDS LLC | 66,018,000 | $70,980,000 | 0.49% |
| ZAZOVE ASSOCIATES LLC | 1,500,000 | $1,608,000 | 0.20% |
| IRON Financial LLC | 275,000 | $295,000 | 0.15% |
| PALISADE CAPITAL MANAGEMENT, LP | 3,000,000 | $3,216,000 | 0.08% |